The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prophylactic Treatment with Cerium Oxide Nanoparticles Attenuate Hepatic Ischemia Reperfusion Injury in Sprague Dawley Rats
Open accessAbstract
Background: Hepatic ischemia reperfusion is one the main causes for graft failure following transplantation. Although, the molecular events that lead to hepatic failure following ischemia reperfusion (IR) are diverse and complex, previous studies have shown that excessive formation of reactive oxygen species (ROS) are responsible for hepatic IR injury. Cerium oxide (CeO2) nanoparticles have been previously shown to act as an anti-oxidant and anti-inflammatory agent. Here, we evaluated the protective effects of CeO2 nanoparticles on hepatic ischemia reperfusion injury. Methods: Male Sprague Dawley rats were randomly assigned to one of the four groups: Control, CeO2 nanoparticle only, hepatic ischemia reperfusion (IR) group and hepatic ischemia reperfusion (IR) plus CeO2 nanoparticle group (IR+ CeO2). Partial warm hepatic ischemia was induced in left lateral and median lobes for 1h, followed by 6h of reperfusion. Animals were sacrificed after 6h of reperfusion and blood and tissue samples were collected and processed for various biochemical experiments. Results: Prophylactic treatment with CeO2 nanoparticles (0.5mg/kg i.v (IR+CeO2 group)) 1 hour prior to hepatic ischemia and subsequent reperfusion injury lead to a decrease in serum levels of alanine aminotransaminase and lactate dehydrogenase at 6 hours after reperfusion. These changes were accompanied by significant decrease in hepatocyte necrosis along with reduction in several serum inflammatory markers such as macrophage derived chemokine, macrophage inflammatory protein-2, KC/GRO, myoglobin and plasminogen activator inhibitor-1. However, immunoblotting demonstrated no significant changes in the levels of apoptosis related protein markers such as bax, bcl2 and caspase 3 in IR and IR+ CeO2 groups at 6 hours suggesting necrosis as the main pathway for hepatocyte death. Conclusion: Taken together, these data suggest that CeO2 nanoparticles attenuate IR induced cell death and can be used as a prophylactic agent to prevent hepatic injury associated with graft failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning
Jaeschke, H. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00342.2002 · Cited by 852
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons
Das, M., Patil, S., Bhargava, N., Kang, J.-F., Riedel, L. M., Seal, S., & Hickman, J. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.036 · Cited by 760
Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu
Peralta, C., Jiménez-Castro, M. B., & Gracia-Sancho, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.017 · Cited by 616
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury
Jaeschke, H., & Lemasters, J. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01209-5 · Cited by 589
Jaeschke, H. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00568.2005 · Cited by 475
Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury
Lentsch, A. B., Kato, A., Yoshidome, H., McMasters, K. M., & Edwards, M. J. (2000) · Hepatology · doi:10.1053/jhep.2000.9323 · Cited by 456
NIU, J., AZFER, A., ROGERS, L., WANG, X., & KOLATTUKUDY, P. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.031 · Cited by 443
Factors in the Pathophysiology of the Liver Ischemia-Reperfusion Injury
Montalvo-Jave, E. E., Escalante-Tattersfield, T., Ortega-Salgado, J. A., Piña, E., & Geller, D. A. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.06.015 · Cited by 389
Mechanism of Cell Death During Warm Hepatic Ischemia–Reperfusion in Rats: Apoptosis or Necrosis?
Gujral, J. S., Bucci, T. J., Farhood, A., & Jaeschke, H. (2001) · Hepatology · doi:10.1053/jhep.2001.22002 · Cited by 375
Lentsch, A. B., Yoshidome, H., Cheadle, W. G., Miller, F. N., & Edwards, M. J. (1998) · Hepatology · doi:10.1002/hep.510270226 · Cited by 334
Bio‐distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice
Hirst, S. M., Karakoti, A., Singh, S., Self, W., Tyler, R., Seal, S., & Reilly, C. M. (2013) · Environmental Toxicology · doi:10.1002/tox.20704 · Cited by 300
Jaeschke, H., & Woolbright, B. L. (2012) · Transplantation Reviews · doi:10.1016/j.trre.2011.10.006 · Cited by 292
Estevez, A. Y., Pritchard, S., Harper, K., Aston, J. W., Lynch, A., Lucky, J. J., Ludington, J. S., Chatani, P., Mosenthal, W. P., Leiter, J. C., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.006 · Cited by 274
Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
Giri, S., Karakoti, A., Graham, R. P., Maguire, J. L., Reilly, C. M., Seal, S., Rattan, R., & Shridhar, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054578 · Cited by 273
Oró, D., Yudina, T., Fernández-Varo, G., Casals, E., Reichenbach, V., Casals, G., González de la Presa, B., Sandalinas, S., Carvajal, S., Puntes, V., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.020 · Cited by 215
JNK mediates hepatic ischemia reperfusion injury
Uehara, T., Bennett, B., Sakata, S. T., Satoh, Y., Bilter, G. K., Westwick, J. K., & Brenner, D. A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.030 · Cited by 214
Caputo, F., De Nicola, M., Sienkiewicz, A., Giovanetti, A., Bejarano, I., Licoccia, S., Traversa, E., & Ghibelli, L. (2015) · Nanoscale · doi:10.1039/c5nr03767k · Cited by 189
Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity
Pešić, M., Podolski-Renić, A., Stojković, S., Matović, B., Zmejkoski, D., Kojić, V., Bogdanović, G., Pavićević, A., Mojović, M., Savić, A., et al. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.03.013 · Cited by 175
Li, J., Wang, F., Xia, Y., Dai, W., Chen, K., Li, S., Liu, T., Zheng, Y., Wang, J., Lu, W., et al. (2015) · Marine Drugs · doi:10.3390/md13063368 · Cited by 160
Bhargava, Arya, A., Sethy, N. K., Singh, S. K., & Das, M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s53032 · Cited by 142
Yokel, R. A., Hussain, S., Garantziotis, S., Demokritou, P., Castranova, V., & Cassee, F. R. (2014) · Environ. Sci.: Nano · doi:10.1039/c4en00039k · Cited by 136
Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation
Bhogal, R. H., Curbishley, S. M., Weston, C. J., Adams, D., & Afford, S. C. (2010) · Liver Transplantation · doi:10.1002/lt.22157 · Cited by 136
The Effect of Cerium Oxide Nanoparticle Valence State on Reactive Oxygen Species and Toxicity
Dunnick, K. M., Pillai, R. C., Pisane, K. L., Stefaniak, A. B., Sabolsky, E. M., & Leonard, S. S. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0297-4 · Cited by 121
Effect of cerium oxide nanoparticles on inflammation in vascular endothelial cells
Gojová, A., Lee, J.-T., Jung, H., Guo, B., Barakat, A. I., & Kennedy, I. M. (2009) · Inhalation Toxicology · doi:10.1080/08958370902942582 · Cited by 104
Rocca, A., Moscato, S., Ronca, F., Nitti, S., Mattoli, V., Gıorgı, M., & Ciofani, G. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.001 · Cited by 102
Yang, M., Antoine, D. J., Weemhoff, J. L., Jenkins, R. E., Farhood, A. I., Park, K. B., & Jaeschke, H. (2014) · Liver Transplantation · doi:10.1002/lt.23958 · Cited by 102
Manne, N. D. P. K., Arvapalli, R., Nepal, N., Shokuhfar, T., Rice, K. M., Asano, S., & Blough, E. R. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0135-z · Cited by 69
Self-citationThe Effects of Two Anesthetics, Propofol and Sevoflurane, on Liver Ischemia/Reperfusion Injury
Xu, Z., Yu, J., Wu, J., Feng, Q., Wang, H., Wang, Z., & Zhou, W. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443103 · Cited by 69
TRAF1 is a key mediator for hepatic ischemia/reperfusion injury
Zhang, X., Zhang, R., Zhang, R., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.411 · Cited by 46
Richter, J. R., Sutton, J. M., Belizaire, R. M., Friend, L. A., Schuster, R. M., Johannigman, T. A., Miller, S. G., Lentsch, A. B., & Pritts, T. A. (2014) · Shock · doi:10.1097/shk.0000000000000253 · Cited by 46
Zhang, C., Liao, Y., Li, Q., Chen, M., Zhao, Q., Deng, R., Wu, C., Yang, A., Guo, Z., Wang, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066382 · Cited by 42
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury
Hochhauser, E., Lahat, E., Sultan, M., Pappo, O., Waldman, M., Sarne, Y., Shainberg, A., Gutman, M., Safran, M., & Ben‐Ari, Z. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430165 · Cited by 38
Manne, N. D. P. K., Arvapalli, R., Nepal, N., Thulluri, S., Selvaraj, V., Shokuhfar, T., He, K., Rice, K. M., Asano, S., Maheshwari, M., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001258 · Cited by 32
Self-citationCasillas-Ramírez, A., Zaoualí, M. A., Padrissa‐Altés, S., Mosbah, I. B., Pertosa, A. M., Alfany-Fernández, I., Bintanel-Morcillo, M., Xaus, C., Rimola, A., Rodés, J., et al. (2009) · Endocrinology · doi:10.1210/en.2008-1458 · Cited by 30
PTPRO-Associated Hepatic Stellate Cell Activation Plays a Critical Role in Liver Fibrosis
Zhang, X., Tan, Z., Wang, Y., Tang, J., Jiang, R., Hou, J., Zhuo, H., Wang, X., Ji, J., Qin, X., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369746 · Cited by 28
Persistent Hepatic Structural Alterations Following Nanoceria Vascular Infusion in the Rat
Tseng, M. T., Fu, Q., Lor, K., Fernandez-Botrán, R., Deng, Z., Graham, U. M., Butterfield, D. A., Grulke, E. A., & Yokel, R. A. (2013) · Toxicologic Pathology · doi:10.1177/0192623313505780 · Cited by 27
Induction of type 1 plasminogen activator inhibitor in human liver ischemia and reperfusion
Inoue, K., Sugawara, Y., Kubota, K., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80276-7 · Cited by 17
Liu, C., Wang, X., Chen, Z., Zhang, L., Wu, Y., & Zhang, Y. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.07.143 · Cited by 9
Üstün, Y. B., Köksal, E., Kaya, C., Şener, E. B., Aksoy, A., Yarım, G. F., Kabak, Y. B., & Gülbahar, M. Y. (2014) · International Surgery · doi:10.9738/intsurg-d-14-00121.1 · Cited by 4
Cited by
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Dhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,525
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Metadata
- Authors
- Manne, N. D. P. K., Arvapalli, R., Graffeo, V. A., Bandarupalli, V. V. K., Shokuhfar, T., Patel, S., Rice, K. M., Ginjupalli, G. K., & Blough, E. R.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 42
- Issue
- 5
- Pages
- 1837-1846
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2739873258
- Cited by
- 702
- References
- 39
- FWCI
- 62.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.